The BFiORS Trial, sponsored by Assiut University, aims to validate the Body Fat Index (BFI) as a novel sonographic tool for predicting high-risk pregnancies, specifically focusing on gestational diabetes mellitus (GDM) and pre-eclampsia. Given the increasing prevalence of obesity among reproductive-aged women and its associated risks, this trial addresses a significant unmet need in obstetric care. The potential for BFI to serve as a cost-effective, non-invasive screening method could position it favorably in the maternal health market, particularly as healthcare systems seek to improve outcomes while managing costs. The trial's collaboration with reputable institutions such as Baylor College of Medicine enhances its credibility and may facilitate future partnerships or commercialization opportunities. However, the overall status of the trial is currently listed as 'Not Yet Recruiting,' which may delay market entry and impact investor interest.